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PLATELET-RICH PLASMA FOR THE TREATMENT OF PARTIAL ROTATOR 
CUFF TEARS 
ANTONIO LOCCISANO 
ABSTRACT 
Rotator cuff tears are a common injury impacting a large and diverse 
group of patients and refer to a partial or full discontinuation of one or more of the 
muscles or tendons comprising the shoulder complex. It may occur as a result of 
traumatic injury, applied weight, overuse, or intrinsic degeneration over a period 
of years. The incidence of rotator cuff tears has been found to increase with age. 
Though not a life-threatening condition, rotator cuff tears adversely affect the 
quality of one’s lifestyle causing significant pain, weakness, and limitation of 
motion that hinders a person from performing routine daily activities as 
adequately and frequently as desired.  
Data from cadaveric studies suggest that as many as 65% of individuals 
over the age of 70 have a partial-thickness rotator cuff tear. Oftentimes, rotator 
cuff tears are asymptomatic which can make diagnosis and early treatment 
challenging. The decision to pursue operative versus conservative management 
is often controversial. Though surgical intervention may provide more immediate 
pain relief and functional improvement, it portends a higher risk of morbidity than 
conservative measures, particularly with an older demographic of patients. 
Moreover, surgical repair is often followed by long recovery periods and has 
variable outcomes. A number of conservative treatment options are currently 
  vii 
being utilized for the management of partial rotator cuff tears including oral 
medication, corticosteroid injection, and targeted physical therapy.  
This review seeks to assess an innovative, biologic approach to treating 
partial rotator cuff tears using autologous platelet-rich plasma (PRP). The use of 
PRP for the conservative management of both degenerative and acutely injured 
tissues is quickly becoming a more popular option within the clinical community. 
PRP treatment has received significant attention from the media and has been 
used by several professional athletes as a means of expediting the healing 
process. The appeal of PRP stems from the fact that it is produced from a 
patient’s own blood. After a blood sample is obtained, it is placed into a 
centrifuge, a tool used to separate the blood into its many components. A large 
concentration of platelet-enriched plasma can then be collected and augmented 
before administration to an injured area of bone or soft tissue, such as a tendon 
or ligament. Platelets contain an abundance of growth factors essential for 
cellular recruitment, proliferation, and specialization required for the healing 
process. PRP is given to a patient via an injection, often under ultrasound 
assistance for more precise placement.  
  viii 
This study reviewed a collection of current literature on the efficacy of PRP 
in rotator cuff repair. Published studies have generally illustrated a general trend 
towards effectiveness, suggesting PRP may improve patient outcomes and 
prevent the need for surgery in patients with partial rotator cuff tears. Study 
designs and results have proved to be inconsistent at times. However, further 
clinical investigation is required to validate the use of PRP as an additional non-
surgical treatment option.  
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INTRODUCTION 
 
Rotator cuff tears (RCTs) are a common injury among a diverse group of 
patients, with prevalence of injury increasing linearly with age [52]. It is a 
condition typically characterized by weakness and pain in the shoulder that is 
aggravated by overuse, applied weight, raising/lowering or rotating the involved 
arm, as well as overhead physical activities such as tennis, baseball, and 
swimming [45]. The supraspinatus muscle and tendon are the most common 
sites of injury and can be damaged by both traumatic injuries and degenerative 
changes [15].  
Data from cadaveric studies suggest that as many as 65% of individuals 
over the age of 70 years have a partial-thickness rotator cuff tear [34]. 
Oftentimes, rotator cuff tears are asymptomatic, which can make diagnosis and 
early treatment challenging [25, 52]. The decision to pursue operative versus 
non-operative management is therefore often controversial. Surgical 
management may provide more immediate pain relief and functional 
improvement, but it portends a higher risk of morbidity than conservative 
measures, particularly with an older population of patients [31]. Moreover, 
surgical repair is often followed by a long recovery period and has variable 
outcomes [31]. Current conservative treatments of partial rotator cuff tears 
include activity modification, oral medication, corticosteroid injection, and/or 
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targeted physical therapy [28, 52]. Improperly managed partial rotator cuff tears 
can progress to debilitating full-thickness tears if left untreated [31].  
This review seeks to assess an innovative, biological approach to treating 
RCTs using autologous platelet-rich plasma (PRP), with the goal of distilling a 
safe and readily available, long-lasting treatment option that can be offered to a 
wide range of patients. The use of platelet-rich plasma for the conservative 
management of both degenerative and acutely injured tissues is gaining 
recognition and popularity in the international community of clinician-scientists. A 
large retrospective review on the use of ultrasound-guided PRP injections for 
chronic tendinopathy in various bodily regions reported an 82% improvement in 
symptoms across all surveyed patients [31]. Furthermore, experiential clinical 
data suggests that PRP is often an effective treatment for partial rotator cuff 
tears. Still, supportive data from published literature remains limited and is of 
variable quality and consistency.  
 This paper will first provide relevant background information on the 
anatomical function of the shoulder complex, with an emphasis on the rotator cuff 
and its pathophysiology, and next explore some of the most currently utilized 
therapeutic interventions. The use of PRP as an innovative biologic 
augmentation of rotator cuff repair will then be introduced, and various proposed 
studies involving the use of PRP as an alternative treatment option will be 
discussed, leading to an analysis of patient outcomes and a critique of each 
study’s value. By evaluating the therapeutic value of PRP, this review can 
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potentially validate an additional non-surgical alternative for the treatment of 
partial RCTs and contribute to identifying specific sub-groups of patients and 
pathologies that would gain the great benefit from its use in future studies.  
 
Functional Anatomy of the Shoulder Complex 
The shoulder complex is composed of a number of interconnected bones, 
joints, and a specialized set of soft tissues including muscles, tendons, and 
ligaments that are designed to stabilize the arm and provide optimal mobility to 
the upper extremity. The bony structure of the shoulder complex is primarily 
composed of the humerus (i.e. upper arm bone), the scapula (i.e. shoulder 
blade), and the clavicle (i.e. collarbone) [12]. The clavicle is the most complex 
bone of the three and is composed of a body and three bony extensions: the 
glenoid, the coracoid, and the acromion [15]. The four joints of the shoulder, 
named according to the bone processes they connect, include the glenohumeral, 
acromioclavicular, sternoclavicular, and scapulothoracic [12, 15].  
The glenohumeral joint (Figure 1) is a ball and socket joint that is capable 
of a wider range of motion than any other joint in the body [12, 15]. The rounded, 
ball-shaped head of the humerus is seated in the socket-shaped glenoid cavity of 
the scapula. Because of its increased mobility, the glenohumeral joint is also the 
least stable joint, relying on other components for its maintenance [12, 15]. The 
glenoid cavity covers only a portion of the humeral head and the 
fibrocartilaginous labrum deepens the relatively shallow socket, helping to keep 
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the humeral head in place. A joint capsule enveloping the glenohumeral joint is 
lined by a synovial membrane that secretes fluid to help lubricate, absorb shock, 
and nourish the joint [12, 15] 
The sternoclavicular and acromioclavicular joints work together to 
suspend and stabilize the shoulder girdle as well as contribute to increase 
glenohumeral mobility. Rotation at the acromioclavicular joint and elevation at the 
sternoclavicular joint allow for complete elevation of the arm [15]. The 
scapulothoracic joint represent the articulation connecting the scapula to the 
posterior part of the thorax and is responsible for maintaining the full range of 
motion of the scapula. Scapular motion is essential for overall shoulder mobility 
with a 1:2 degree ratio of motion between the scapulothoracic and glenohumeral 
joints [15].   
Unlike the hip, which is also a ball and socket joint but with a deeper 
socket for stability, the shoulder is constructed for motion more so than stability 
[2, 44]. The humeral ball of the shoulder joint is therefore reliant on the soft 
tissues both for its stability and motion [2, 44]. The rotator cuff consists of four 
muscles and their tendons that connect the humerus to the scapula and provides 
stability to the shoulder while allowing it to rotate [2, 44]. It is formed by 
attachment to the joint capsule of the supraspinatus muscle anteriorly, the 
infraspinatus and teres minor posteriorly, and the subscapularis muscle anteriorly 
(Figures 2 & 3) [2, 44].  
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Figure 1.  Glenohumeral Joint and Rotator Cuff of the Shoulder Complex:  
This four-panel figure illustrates the glenohumeral joint of the shoulder from an 
anterior view (A) and the accompanying joint capsule (B), as well as the rotator 
cuff of the shoulder with the associated bursae visible (C) and from a lateral view 
(D).  
Source: Morton, D.A., Foreman, K.B., & Albertine, K.H. The Big Picture: Gross 
Anatomy 
Figure downloaded from http://www.accessmedicine.com 
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Figure 2. Posterior view of the Shoulder Complex with Rotator Cuff 
Muscles: This figure illustrates rotator cuff muscles originating on the posterior 
side of the shoulder: the supraspinatus, infraspinatus, and teres minor. The 
supraspinatus muscle attaches to the greater tuberosity of the humeral head by 
passing underneath the acromion, the bony process of the scapula. It is 
responsible for initiating arm elevation and for abduction of the shoulder. The 
infraspinatus also attaches to the greater tuberosity of the humeral head and is 
responsible for external arm rotation. The teres minor works with the 
infraspinatus to provide external rotation. 
Source: Tintinalli, J.E., Stapczynski, J.S., Ma, O.J., et al. Tintinalli’s Emergency 
Medicine: A Comprehensive Study Guide, 7th Edition.  
Figure downloaded from http://www.accessmedicine.com 
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Figure 3: Anterior View of Shoulder Complex with Rotator Cuff Muscles: 
This figure details the rotator cuff muscle originating on the anterior aspect of the 
shoulder. The subscapularis muscle is the only rotator cuff muscle that arises 
from the anterior aspect of the scapula. It attaches to the lesser tuberosity of the 
humeral head and provides internal rotation of the arm. Also illustrated is the long 
head of the biceps as well as the acromion and coracoid, two of the bony 
processes of the scapula. 
Source: Tintinalli, J.E., Stapczynski, J.S., Ma, O.J., et al. Tintinalli’s Emergency 
Medicine: A Comprehensive Study Guide, 7th Edition.  
Figure downloaded from http://www.accessmedicine.com  
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Pathophysiology 
Though the shoulder complex allows for the greatest range of motion in 
the arm, increased mobility comes at a price, often leading to instability or 
impingement of the soft tissue or bony structures of the shoulder and consequent 
pain [2]. Rotator cuff tears refer to structural failure and/or tissue disruption in any 
of the four distinct muscles and tendons comprising the rotator cuff [2, 15]. A tear 
causing rotator cuff disruption that does not extend all the way through the 
tendon is termed a partial-thickness rotator cuff tear (PT RCT). PT RCTs are 
more prevalent than full-thickness tears and do not lead to retraction of the 
muscle-tendon unit [10]. A tear that involves complete discontinuation of rotator 
cuff fibers is termed a full-thickness tear (FT RCT), resulting in contact between 
the articular and bursal spaces [10].  
RCTs are one of the most common shoulder problems among a diverse 
group of patients, with the incidence increasing linearly with an aging population 
[23]. Data from cadaveric studies suggest that as many as 65% of individuals 
over the age of 70 have a PT RCT and as many as 28% of individuals over the 
age of 60 have had a FT RCT [52]. Oftentimes, RCTs are asymptomatic, making 
diagnosis and early treatment challenging [25]. Studies have shown that the size 
of a tear could be an important factor in the development of symptoms, and that it 
seems to be a trend toward a correlation between tear size, progression, and the 
development of new symptoms [52].  
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Injuries to the rotator cuff are multifactorial, causing irritation or damage to 
the muscles and tendons. Many theories over time have been proposed to 
explain the etiology of RCTs, which have been categorized into both extrinsic 
and intrinsic factors [52]. The chronic impingement theory first proposed by Neer 
is one of the best-known extrinsic pathologic factors in RCTs [52]. Impingement 
is one of the most frequent causes of shoulder pain in the general population, 
particularly in men and women who remain physically active in their thirties and 
forties [43]. Impingement refers to the mechanical compression and possible 
abrasion of the rotator cuff tendons and serves as a precursor to RCTs if the 
condition progresses (Figure 4). The most common site for an impingement is 
the supraspinatus tendon and is brought on by repetitive overhead use or 
movement of the shoulder above the horizontal plane [15]. This pinching can 
cause inflammation that continues to damage the tendon with repetitive motions 
and may involve thickening of the tendon [43]. Swelling within muscle tissue 
decreases its vascularity, causing the muscle to fray [43].  
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Figure 4. Impingement of the Subacromial Bursa and Rotator Cuff: This 
figure illustrates the mechanical compression and potential abrasion of rotator 
cuff muscles. When a person lifts his/her arm above the head, the supraspinatus 
and subacromial bursa may become pinched between the acromion and 
coracoacromial arch and the greater tuberosity of the humerus. This pinching can 
cause inflammation that continues to damage the tendon with repetitive motions 
and may involve thickening of the tendon. 
Source: Tintinalli, J.E., Stapczynski, J.S., Ma, O.J., et al. Tintinalli’s Emergency 
Medicine: A Comprehensive Study Guide, 7th Edition.  
Figure downloaded from http://www.accessmedicine.com  
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Other important extrinsic factors include mechanical overuse of the 
shoulder, dislocations, and fractures of the greater tuberosity of the humeral 
head [49]. Factors that impede the natural healing process of tissues healing 
may also contribute to RTCs. Studies have shown that nicotine, for example, has 
a deleterious effect on tendon healing [16, 52]. Smokers are less likely to 
respond favorably to rotator cuff repair operations, with reduced post-operative 
function and satisfaction compared to nonsmokers [16]. Diabetes is another 
potential risk factor for RCTs [52]. In a study on patients with asymptomatic 
rotator cuff disease, it was found that histologic rotator cuff tendon changes 
related to age are more common in diabetics and that diabetic patients 
demonstrated a more restricted shoulder range of motion, higher incidence in re-
tear rates after surgical repair, and higher rates of complications and infections 
after repair [52].  
 Clinical evidence suggests that most RCTs are caused by intrinsic factors 
such as microtrauma or degeneration [34]. Rotator cuffs may be torn from a 
single traumatic injury or, more commonly, from overuse of the muscles and 
tendons over a prolonged period of time that leads to the intrinsic degeneration of 
a tendon and eventual tear [34, 35]. The frequency and distribution of these 
degenerations suggest that they are common changes involved in the early 
degeneration of rotator cuff tendons before tearing occurs [52].  
 Studies conducted by Riley et al. in 2002 also point to extracellular matrix 
(ECM) modifications as another important intrinsic factor in the etiology of RCTs 
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[52]. ECM is the substrate to which cells adhere, migrate, and differentiate. It 
imparts information to cells and tissues by providing cell-binding motifs in its own 
proteins or by presenting growth factors (GFs) to the cells [52]. Physiologic and 
pathologic modifications to the ECM seem to be the most important intrinsic 
factors involved in tendinopathies and tendon ruptures. Transglutaminases (TGs) 
have found to be tied to the formation of hard tissue development, matrix 
maturation, and mineralization [52]. They are important in maintaining the 
structural integrity of tendons thanks to their crosslinking function under normal 
conditions [52]. Injured supraspinatus tendons have demonstrated a reduction in 
TG2 protein expression, one of nine different TGs found in mammals, and the fall 
of TG2 may mean the exhaustion of the tendon’s capability to repair [52].  
 
Diagnosis of Rotator Cuff Tears 
Diagnosis of rotator cuff injury is made through the careful collection of a 
patient’s medical history and physical examination. Practically speaking, it can be 
very difficult to distinguish between a FT RCT and PT RCT, or even between 
rotator cuff injuries from some other inflammatory rotator cuff condition in this 
manner [15]. The diagnosis is primarily clinically based on the finding of rotator 
cuff weakness upon examination of a patient with a history of chronic shoulder 
pain or acute shoulder pain after significant trauma [15, 25]. Routine shoulder 
radiographs are useful tools to evaluate RCTs and associated intra-articular 
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pathology, with magnetic resonance imaging (MRI) and ultrasound being two of 
the most common techniques used [48].  
Ultrasound has proven to be a very valuable tool for diagnosing rotator 
cuff disease, particularly full-thickness RCTs [55]. It is capable of effectively 
evaluating patients with shoulder instability and postoperative patients with 
metallic artifacts that would otherwise obscure MRI findings. However, the 
ultrasound technique is significantly dependent on an experienced operator and 
appropriate equipment for the most accurate readings and is thus less practical 
in clinical settings [55]. Conventional MRI, on the other hand, is an extremely 
useful imaging modality in the evaluation of patients with shoulder pain (Figure 
5). Studies have found MRI to have a sensitivity of 100% and specificity of 95% 
for diagnosing FT RCTs, as well as a sensitivity of 82% and a specificity of 85% 
for PT RCTs [55].  
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Figure 5. MRI Scans of Normal and Torn Rotator Cuffs: The figures illustrate 
the radiographic difference of a normal rotator cuff (left) as compared with a torn 
rotator cuff (right). Whereas the image of the normal rotator cuff displays a purely 
biack signal band, denoted below the tip of the red arrow, the black band on the 
right is interrupted by a white signal, indicating a tear in the rotator cuff fibers.  
Source: Mishra, A. MRI Scans of Normal and Torn Rotator Cuffs 
Figure downloaded from http://www.EMEDX.com 
 
Treatment Options 
The decision to pursue operative versus non-operative management of 
rotator cuff tears is often controversial. To date, no definitive consensus exists as 
to what is the best management for patients, and new therapeutic options are 
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continuously being assessed and validated for their efficacy, often with 
contrasting results [28]. The published success rate of non-operative 
management varies widely, ranging from 33%-92%. Although current evidence is 
not sufficient to reach clear indications for conservative management of RCTs, 
several authors recommend non-operative treatment for patients experiencing 
pain without any dramatic or progressive signs of weakness [28]. Positive 
correlations have also been found with a number of prognostic factors such as 
clinical presentation, duration of symptoms, and tear size. Symptom duration 
lasting less than one year and tear size less than 1 cm, for instance, are good 
predicators of beneficial results with conservative treatment [28].  
Surgical management may provide more immediate pain relief and 
functional improvement in certain instances; however, it portends a higher risk of 
morbidity than conservative measures, particularly in the elderly population that 
is affected by a number of co-morbidities. The elderly make up the majority of 
patients with rotator cuff dysfunction, with marked disabilities leading to functional 
decline. Current conservative treatments of partial RCTs include modification of 
daily activity, corticosteroid injection, oral medication such as non-steroidal anti-
inflammatory drugs (NSAIDs), and/or targeted physical therapy [31]. The aim of 
conservative management is to decrease shoulder pain and regain function while 
minimizing risk of further injury to the rotator cuff tendons.  
 A. Physical Therapy 
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Physical therapy (PT) mainly consists of stretching and strengthening 
exercises that patients perform at home following a scheduled program or under 
the supervision of a physical therapist [28]. The characteristics of an exercise 
program, however, are not standardized. An exercise program should be tailored 
to the location of the tear and aim to decrease stiffness and improve function and 
range of motion.  
 B. Medications 
Systemic drugs for patients experiencing shoulder pain include NSAIDs. 
Recently, cyclo-oxygenase-2 (COX-2) selective inhibitors have also been 
introduced for the management of shoulder pain [28]. Both NSAIDs and COX-2 
inhibitors demonstrate short-term efficacy in controlled clinical studies and both 
present adverse side effects. Conventional NSAIDs cause adverse 
gastrointestinal reactions in as many as 76% of patients [28]. NSAIDs have also 
exhibited adverse renal, dermatological, and neurological effects in certain 
instances [28].  In instances where patients have used either NSAIDs or COX-2 
inhibitors for more than 3 months, concerns have arisen about potential 
cardiovascular risk [28, 46]. Use of such medication is therefore recommended 
for short periods of time. Other common adverse effects include interference with 
diuretics, beta-blockers, angiotensin-converting enzyme (ACE) inhibitors (used 
primarily for the treatment of hypertension and congestive heart failure), and 
angiotensin type-2 receptor antagonists, thereby influencing control of blood 
pressure in patients with hypertension [28].  
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 C. Corticosteroid injections 
Several types of intra-articular injections are commonly used in clinical 
settings for alleviation of pain. With regards to shoulder pain treatment, Injections 
may be administered either into the subacromial space or to the glenohumeral 
and acromioclavicular joints, and they are typically administered in a solution 
consisting of a short-acting anesthetic, a longer-acting anesthetic, and a 
corticosteroid such as cortisone [55]. Corticosteroids are generally recommended 
in conjunction with PT and oral NSAIDs, providing more rapid relief for patients in 
order to undergo PT programs with less discomfort [28]. Reported outcome 
measures are variable, and the literature on corticosteroid injection in patients 
with RCTs is limited. No significant benefits were found in patients with partial 
RCTs with symptoms lasting longer than 6 months who had failed PT and a trial 
of NSAIDs [28].  
An important concern is the accuracy of delivery of the medication into the 
desired target. A difference in the effectiveness of the intervention performed 
under radiographic control, commonly under ultrasound guidance for instance, 
has been reported in some studies [28]. Though an effective method for short-
term alleviation of pain, the administration of corticosteroids into tendon 
structures can also limit and/or inhibit their use for periods of time. They can also 
cause necrosis of collagen fibers, weakness, and increased risk of rupture. For 
this reason, more than two injections per year, once every 6 months, is 
discouraged [28].  
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 Patients enduring long-term pain may thus benefit from sodium 
hyaluronate injection as opposed to corticosteroids. Sodium hyaluronate is a 
normal component of synovial fluid and therefore works to maintain physiological 
joint friction because of its inherent viscosity [28]. Its efficacy has been proven in 
a small series of patients with RCTs, with significant benefits over placebo, and 
has demonstrated a lowering in pain, less need for oral analgesics, and 
improvement in range of motion [47]. Presenting minimal to no side effects, it 
seems to be a valid treatment option [47]. However, further studies are needed to 
confirm its efficacy.  
D.  Surgical intervention 
Over the last two decades, surgical treatment of RCTs has shifted from 
the use of open repair to arthroscopic techniques including single-row and 
double-row anchor suture constructs as concerns over the durability and strength 
of initial repair methods, as well as incidence of rotator cuff re-tear, increasingly 
arose [12]. Open repair was the oldest surgical method used for treating RCTs, 
often requiring an open incision several centimeters long depending on the 
extent of the tear. The surgeon makes the incision over the shoulder and 
detaches the deltoid to better see and gain access to the torn tendon [2]. An 
open repair today may be a good option if the tear is large or complex or if 
additional reconstruction, such as a tendon transfer, is indicated [2]. Over the 
years, new technology and improved surgeon experience have led to less 
invasive surgical procedures.  
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Arthroscopic surgery is a minimally invasive technique that allows 
orthopedic surgeons to assess, and treat in certain cases, a range of conditions 
affecting the shoulder joint. During the procedure, the surgeon makes small 
incisions or portals in the affected joint and then inserts a micro camera and fiber 
optics to light the interior space [2, 54]. Pictures obtained with the camera are 
then projected onto a video screen in the operating suite (Figure 6) [2, 54]. 
Because the arthroscopic camera and surgical instruments are thin, the 
orthopedic surgeon is able to use very small cuts rather than larger incisions 
needed for standard, open surgery [2, 54].  
 
Figure 6. Arthroscopic view of a Partial Rotator Cuff Tear. The figure 
illustrates the image-capturing capabilities of arthroscopic camera during surgery. 
The left image denotes a partial rotator cuff tear at the onset of the procedure, 
while the right image is that of the rotator cuff after debridement of devitalized 
tissue.  
Source: Mishra, A. Arthroscopy Pictures of a Partial Rotator Cuff Tear 
Figure downloaded from http://www.EMEDX.com 
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The mini-open repair combines an open repair technique with arthroscopy 
to reduce the size of the incision required to perform rotator cuff repair, typically 
3-5 cm in length [2]. Small portals are created to insert the arthroscopic and an 
additional incision is created to visualize the rotator cuff [2]. The surgeon reaches 
the tear by splitting the deltoid muscle along the lines of its fibers rather than 
detaching it fully. It is then kept in place by a temporary suture to prevent further 
damage while the repair is being completed. The mini-open approach thus 
reduces the chance of deltoid injury that may occur with a traditional open 
technique.  
Regardless of the technique utilized, the repair of the rotator cuff itself 
involves suturing the torn, loose ends of the involved tendon back together and 
anchoring the tendon back to the humerus. A full or partial repair may be 
performed, depending on the severity of the tear. As its name implies, full repair 
is the complete repair of the tear. When a complete repair is not feasible, such as 
when the tear is extremely large, a partial repair may be performed in order to 
restore adequate function and delay the progression of the tear.   
Debridement involves removing loose fragments of tendon, bursa, and 
other debris from the space in the shoulder where the rotator cuff moves [15]. In 
certain instances, the acromion may require smoothing or a portion of the bones 
forming the AC joint may need to be removed in order to decrease mechanical 
impingement of the acromion on the rotator cuff. Acromioplasty involves the 
removal of bone from the underside of the acromion, thus creating more room in 
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the subacromial space [15]. If the rotator cuff is damaged extensively, the patient 
may require complete rotator cuff reconstruction with a tendon obtained from 
elsewhere in the body [15].  
RCTs are often surgically repaired when symptoms have failed to resolve 
with non-operative treatment [7]. Various studies have demonstrated the long-
term favorable outcomes of surgical repair, with a reported 94% survivorship at 5 
years and 83% at 10 years [7]. Moreover, clinical results after rotator cuff repair 
have shown to be satisfactory regardless of the operative technique used [24]. 
Average satisfaction rates of 85% have been reported for open surgery and 84%-
95% for arthroscopic surgery [24].  
 
 Biological Augmentation of Rotator Cuff Tears 
Despite satisfactory results, the incidence of persistent tendon defects or 
re-tears is still significant. 85% of surgical repair failures occur during the first six 
months of recovery, with 74% occurring in the first three months [7]. Two years 
after arthroscopic rotator cuff repair, 70% of supraspinatus repairs and only 27% 
of supraspinatus with infraspinatus repairs remained intact [7].  
Several studies have demonstrated that native tendon-bone insertions are 
not fully restored after rotator cuff repair [34]. The native insertion site of the 
rotator cuff is composed of four zones that include the tendon itself, 
unmineralized fibrocartilage, mineralized fibrocartilage, and bone [36]. After being 
inflicted with injury, repaired tendons undergo healing through the formation of 
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fibrous scar tissue rather than through the regeneration of a histologically normal 
insertion [36]. Consequently, repaired tendons have inferior mechanical 
properties and are more susceptible to re-tearing. Considering the relatively high 
percentages of repair failure, it is thus important to explore techniques of 
biological augmentation to reduce the post-surgical recurrence rate and improve 
long-term shoulder function after rotator cuff repair [36]. Furthermore, as the 
degenerative torn ends of rotator cuffs do not appear to contribute to healing, 
coupled with the fact that tendon healing is naturally slow, an additional biological 
strategy is required to improve the tissue quality of torn ends and to aid the 
regeneration of native tendon-to-bone insertions [23].  
1. Delivery of Cells and Growth Factors to the Healing Rotator Cuff 
 Several strategies have been proposed to enhance tendon healing, a 
complex process characterized by a series of events triggered by injury to the 
tissue itself. This sequence includes inflammation, repair, and remodeling [37]. 
Recently, research has focused on regenerative therapies such as the delivery of 
growth factors to the site of injury. Growth factors are a subset of cytokines, or 
soluble proteins affecting cellular behavior, that help induce cellular division, 
maturation, and differentiation [37].  
A number of GFs are released in the repair phase of the healing process, 
acting through specific cell surface receptors on appropriate target cells in to 
promote cellular proliferation and matrix deposition. The temporal expression of 
various GFs varies, with some triggered as early as one week after injury. These 
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GFs include basic fibroblast growth factor (bFGF), bone morphogenetic protein 
12, 13, and 14 (BMP-12, 13, 14), cartilage oligomatrix protein (COMP), 
connective tissue growth factor (CTGF), platelet-derived growth factor (PDGF-β), 
transforming growth factor-beta (TGF- β), and insulin-like growth factor-1 (IGF-1) 
[37]. GF selection, timing of application during the repair process, and method of 
delivery are all factors focused on in this area of rotator cuff repair research today 
[37].   
2. Extracellular Matrix Augmentation 
Scaffolds are often used in orthopedics to promote native tissue ingrowth 
and can be composed of either natural or synthetic materials [37]. They provide 
mechanical support and have biological properties that may favorably influence 
cellular proliferation and differentiation and consequently improve tendon-to-bone 
healing [8]. Additionally, scaffolds help mediate cellular recruitment and 
adherence, nutrient diffusion, and GF delivery [37]. Sources of scaffolds may 
include transplanted host tissue, naturally derived polymers such as collagen, 
synthetic polymers, or in situ host tissue such as biceps tendon or deltoid 
muscle, both of which previously been utilized to bridge a residual defect during 
massive cuff RCT repair [8].  
3. Platelet Rich Plasma 
The use of PRP injections as a promising alternative for conservative 
management of both degenerative and acutely injured tissues has quickly gained 
recognition and popularity among the scientific community. The idea of utilizing 
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PRP as a viable treatment option dates back to the 1990’s when the first seminal 
paper was published on the use of PRP in augmenting maxillofacial surgery [36]. 
Today, clinical applications of PRP include periodontal and maxillofacial surgery, 
plastic surgery, treatment of chronic skin and soft tissue ulcers, treatment of bone 
fractures, bone tendon healing, and tendinopathies [36]. As previously 
mentioned, injured tendons are marked by a degenerative process and poor 
healing response. The most common form of tendon healing is by inflammation, 
but tendons taken from chronically degenerative conditions demonstrate no 
inflammation and poor vascularization, a factor that may account for their 
markedly slow healing rate. It has thus been hypothesized that improving 
angiogenesis and augmenting tissue remodeling by inducing the release of 
fundamental GFs such as vascular endothelial growth factor (VEGF) via PRP 
administration can positively affect healing response [19].   
The theory supporting the use of PRP in treating various musculoskeletal 
conditions is based on the concept of reparative formation. In this context, 
platelets play an essential role in the healing process through the normal 
secretion of GFs and recruitment of reparative cells [19]. PRP is a platelet 
concentrate produced from a person’s own blood that typically contains more 
than one billion platelets/μL, a figure representing a 3- to 5-fold increase in the 
concentration of platelets when compared with the normal concentration present 
in whole blood [7, 23]. Within platelets are dense alpha granules that contain a 
myriad of cytokines and growth factors that help to promote wound healing. 
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PDGF, TGF-β, IGF-1, VEGF, bFGF, epidermal growth factor (EGF), and 
hepatocyte grown factor (HGF) are a few of the GFs contained within the alpha 
granules, which are proven to be powerful agents in stimulating duplication, 
activation, and growth of mesenchymal cells—mainly, osteoblasts, fibroblasts, 
and endothelial cells--as well as tissue regeneration [7, 23]. Furthermore, these 
GFs also promote cell proliferation, migration, and synthesis of ECM proteins. 
With such a high concentration of platelets and concurrently increased GFs, PRP 
thus has the potential to improve healing of rotator cuff tears.  
 PRP injections are widely accepted by patients because the injection is 
considered an autologous blood product that promotes the body’s own natural 
healing process [19, 36]. It is prepared by drawing blood from the patient and 
subsequently spinning the sample in a centrifuge, a tool utilized to separate the 
various components of the blood (Figure 7). The platelet-concentrated 
component is then extracted and treated before it is administered to an injured 
area of bone or soft tissue such as a tendon or ligament.  
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Figure 7. Platelet Rich Plasma Preparation Device. One of several PRP 
preparation systems (GPS III Biomet, Warsaw, IN) currently available for 
outpatient use. PRP is commonly prepared via centrifugation, separating whole 
blood into its components: whole red blood cells (bottom of well), platelets, and 
white blood cells. Plasma can be further divided into platelet-poor plasma (top 
yellow column) and platelet-rich plasma (white middle column).  
Source: Mishra A, Randelli P, Barr C, Talamonti T, Ragone V, Cabitza P. 
Platelet-rich plasma and the upper extremity. Hand Clin. 2012; 28(4): 481-491. 
 
The risk of acquiring a transmitted blood-borne infection or experiencing 
an anaphylactic reaction is virtually nonexistent with PRP injections [31]. PRP 
also generally has a lower cost and shorter recovery time compared to surgical 
management. The use of PRP for musculoskeletal injuries has thus increased 
significantly over the last few years, given its safety and availability for outpatient 
preparation and delivery.  
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 When evaluating the efficacy of PRP injections, it is important to consider 
the various PRP formulations that may be prepared and consequent differences 
in their biological characteristics such as GF concentration and catabolic enzyme 
content [36]. PRP may be prepared as a pure platelet concentrate via 
centrifugation (leukocyte-poor) or as a mixture with white blood cells (leukocyte-
rich). [2, 36]. Additionally, white blood cells come in several varieties, comprising 
of neutrophils, lymphocytes, and monocytes [36]. PRP application techniques are 
also variable. Platelets can be activated ex vivo with thrombin and/or calcium 
immediately before injection [19]. A network of fibrin then forms, resulting in a 
membrane-like material that can be incorporated into a suture construct [2].  
 
Figure 8. PRP Gel-Like Construct. PRP formulations often activated with  
calcium chloride or thrombins are prepared as a gel-like substance that are then 
sutured into a rotator cuff repair.  
Source: Barber et al. Rotator cuff repair healing influenced by platelet-rich 
plasma construct augmentation. Arthroscopy. 2011; 27(8): 1029-1035. 
This technique can result in immediate release of GFs. Use of PRP in an 
unactivated manner, without thrombin or calcium, allows for application via a 
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syringe or catheter and allow for slow activation via exposure to endogenous 
collagen [19, 36]. This methodology has been shown to result in up to 80% more 
GF release over the same period of time [36]. In surgical applications of PRP 
after arthroscopic repair, the formulation is often treated with calcium chloride or 
thrombin before being administered, allowing for formation of a gel-like clot that 
can be directly applied or sutured at the surgical site (Figure 8) [19, 36].  
Table 1. PRP Classification. To better understand and communicate the value 
of PRP for sports medicine applications, Mishra et al. devised a classification 
system (Table 1), that categorizes various formulations of PRP based on the 
absence or presence of white blood cells and whether the PRP is used in an 
activated or unactivated form. A sub-classification is also incorporated based on 
the platelet concentration. Current literature on the use of PRP on rotator cuffs 
has studied a variety of PRP formulations, an important factor to keep in mind 
when trying to determine the efficacy of the treatment option for RCTs. 
Source: Mishra, A., Harmon K., Woodall J., et al. Sports medicine applications of 
platelet rich plasma. Curr Pharm Biotechnol 2012; 13 (7): 1185-95.  
 
 
Formulation 
White Blood Cells 
(WBCs) 
 
Activated? 
 
Type 1 
 
Increased over baseline 
 
No 
 
Type 2 
 
Increased over baseline 
 
Yes 
 
Type 3 
 
Minimal or no WBCs 
 
No 
 
Type 4 
 
Minimal or no WBCs 
 
Yes 
 
--- 
A: >5x Platelets 
B: <5x Platelets 
 
--- 
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PUBLISHED STUDIES 
 
 
 Preliminary in vitro studies present compelling evidence that PRP may 
stimulate rotator cuff fibroblasts and increase cell proliferation related to the 
growth and repair of rotator cuff tissue. A study conducted by Jo et al. sought to 
examine the effects of PRP on tenocytes isolated and cultured from human 
rotator cuff tendons with degenerative tears [24]. The hypothesis put forth by the 
authors stated that use of a PRP gel formulation would promote tenocyte 
proliferation and induce matrix gene expression and synthesis.  
After obtaining informed consent, tenocytes were isolated and cultured 
from tendon tissues of 9 patients undergoing arthroscopic rotator cuff repair for 
the treatment of degenerative RCT [24]. Inclusion criteria required that all 
patients experienced shoulder pain with an insidious onset and no history of 
trauma [24]. Tendon tissue pieces were 3 x 3 mm in size and obtained after 
debriding severely frayed portions of the lateral edge with a basket forceps [24]. 
To evaluate cell proliferation, tenocytes were cultured with 10% vol/vol platelet-
poor plasma (PPP), PRP activated with calcium, and PRP activated with both 
calcium and thrombin at platelet concentrations of 100, 200, 400, 800, 1000, 
2000, 4000, 8000, and 16,000 x 103/μl for 14 days [24]. Cell number was 
measured at Day 7 and 14 [24]. Throughout the experiments, cells treated with 
2% fetal bovine serum (FBS) were used as controls [24].  
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To investigate matrix gene expression and synthesis, cells were cultured 
with a PPP or PRP gel (10% vol/vol) at a platelet concentration of 1000 x 103/ μl 
for 14 days [24]. Quantitative real-time reverse transcriptase polymerase chain 
reaction (PCR) was then performed to determine the expressions of type I and III 
collagen, decorin (a proteoglycan that binds to type I collagen fibrils and plays a 
role in matrix synthesis), tenascin-C (a glycoprotein expressed in the ECM), and 
scleraxis. Measurements of total collagen and glycosaminoglycan (GAG) 
synthesis were conducted at Days 7 and 14 [24].  
 The authors found that PRP activated with calcium or a combination of 
calcium and thrombin significantly increased cell proliferation at days 7 and 14 in 
a dose-dependent manner, while the addition of thrombin alone moved forward 
the plateau of cell proliferation (Figure 9). At Day 7, PRP activated with calcium 
at a platelet concentration of 4000 x 103 cells/μL demonstrated the greatest cell 
proliferation, with an approximately 5-fold increase, compared with the control 
[24]. At Day 14, the highest proliferation was observed at 8000 x 103 cells/μL for 
PRP-Ca and at 16,000 x 103 cells/μL for PRP-Ca-Thrombin [24]. PRP also 
significantly induced the gene expression of type I collagen at day 7 but not at 
day 14, and it significantly promoted the genetic expression of type III collagen 
both at days 7 and 14 [24]. The ratio of type III/I collagen did not change by a 
statistically significant value at days 7 and 14 [24]. The expressions of decorin 
and scleraxis significantly increased at day 14, whereas that of tenascin-C 
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significantly increased at days 7 and 14 [24]. Finally, PRP significantly increased 
total collagen synthesis at days 7 and 14 and GAG synthesis at day 14 [24].  
The results of the study demonstrated that PRP significantly promoted cell 
proliferation of tenocytes from human rotator cuff tendons with degenerative 
tears as well as enhance matrix gene expression. Total collagen production and 
GAG synthesis was significantly increased as well with PRP [24]. PPP, however, 
was ineffective in stimulating the proliferation of tenocytes or inducing the 
expression and synthesis of tendon matrix aside from decorin at day 14 and total 
collagen. Such findings allude to the importance of bioactive materials released 
from granules in the platelet. The addition of thrombin for activation significantly 
accelerated cell proliferation, particularly at lower concentrations, compared to 
the addition of calcium. This result is most likely due to the initial burst release of 
growth factors upon the addition of thrombin. Taken together, the results of the 
study suggest that PRP might be used as a useful biological tool for regenerative 
healing of RCTs by enhancing the proliferation and matrix synthesis of tenocytes 
from tendons with degenerative tears. 
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Figure 9. Tenocytes isolated and cultured from human rotator cuff tendons.  
Tenocyte cells were isolated from tendon tissue samples and cultured for 14 
days with a PRP gel (10% vol/vol) at platelet concentrations of 100, 200, 400, 
800, 1000, 2000, 4000, 8000, and 16,000 x 103 cells/μL. Fetal bovine serum 
(FBS) and platelet-poor plasma (PPP) wells were used as controls for 
comparison. Note that cell proliferation increases with increasing platelet 
concentration before reaching a maximum concentration at 4000 x 103 cells/μL 
and leveling off afterwards.  
Source: Jo CH, Kim JE, Yoon KS, Shin S. Platelet-rich plasma stimulates cell 
proliferation and enhances matrix gene expression and synthesis in tenocytes 
from human rotator cuff tendons with degenerative tears. Am J Sports Med. 
2012; 40(5): 1035-1045. 
 
A study conducted by Hoppe et al. also sought to examine the effect of 
PRP on cell proliferation and gene expression and synthesis of collagens and 
ECM proteoglycans by studying tenocytes that were isolated from chronically 
retracted rotator cuff tendons and stimulated afterwards with locally applied 
platelet-released growth factors (PRGF) [22]. Tenocytes from eight patients with 
chronic RCTs were cultured for four weeks in 2 different media: standard medium 
and media with an additional 10% PRGF [22]. Cell proliferation was then 
assessed at days 7, 14, 21, and 28 [22]. Messenger RNA (mRNA) levels of 
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collagen I, II, and X, decorin, biglycan, and aggrecan—all components of 
connective tissue that play a role in ECM assembly--were analyzed using real 
time reverse transcriptase PCR [22]. It was found that the proliferation rates of 
tenocytes were significantly higher at all time points when cultured with PRGF. 
After remaining in culture for 21 days, the mRNA levels for collagen I, II, X, 
decorin, aggrecan, and biglycan were all significantly higher in the PRGF 
medium [22]. Locally applied GFs therefore seem to enhance tenocyte 
proliferation in vitro and promote synthesis of ECM components to levels similar 
to those found with insertion of the normal human rotator cuffs. The positive 
results obtained in this study provide compelling evidence for the biological 
augmentation of repaired rotator cuffs with other sources of GFs such as PRP.  
 A limitation of the two previous studies pointed out by Sadoghi et al. is that 
they attempt to assess the clinical impact of PRP on the rotator cuff without first 
attempting to establish a dose-response model or track a longer period of time 
after PRP stimulation [45]. Evidence from in vitro and animal studies suggest that 
the pro-inflammatory agents of PRP might have negative effects, and its use and 
dosage should be chosen deliberately while carefully weighing the benefits with 
potential detrimental effects such as muscle fibrosis after injury [45]. The authors 
therefore sought to elucidate the effects of PRP on rotator cuff fibroblast growth 
and bioactivity, with special attention on the dose-response relationship between 
various PRP concentrations and these outcomes in order to arrive at an optimal 
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dose of PRP concentration to maximize cellular stimulation while reducing 
potential risk [45].  
 Rotator cuff fibroblasts of six patients undergoing arthroscopic cuff tear 
reconstruction were cultured in vitro for 21 days and stimulated with PRP in three 
different concentrations: 1-fold, 5-fold, and 10-fold [45]. Samples were obtained 
for DNA and GAG measurement at 1, 7, 14, and 21 days [45]. The biological 
outcomes were then regressed on the PRP concentration. The authors found 
that the stimulation of fibroblasts with PRP significantly influenced the level of 
cellular proliferation and activity of the human rotator cuff with elevated GAG and 
DNA levels. The dosage of PRP had the significantly highest impact on this 
proliferation using a 1-fold or 5-fold application [45]. PRP therefore was found to 
have a significant effect on fibroblast proliferation of the human rotator cuff in 
vitro, with an optimal benefit using a one- to five-fold PRP concentration [45].  
Follow-up animal studies also demonstrate that PRP may help accelerate 
healing, increase vascularization, and heighten fibroblast response when 
delivered to tendons at the time of arthroscopic rotator cuff repair. A study 
conducted by Hapa et al. sought to determine the effects of local autologous 
PRP injection on tendon-to-bone healing using a previously described rotator cuff 
repair model in rats [20]. 83 total adult male rats were involved in the experiment, 
68 of which were directly included in the study and underwent left shoulder 
rotator cuff repair surgery [20]. The 15 remaining rats were used to collect blood 
for PRP production [20].  
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The 68 rats were next divided into two even groups: the PRP group and a 
control group. The left shoulders of the rats were operated on and the deltoid 
muscle and acromioclavicular arch were retracted in order to achieve complete 
exposure of the rotator cuff tendon [20]. The supraspinatus tendon was then 
detached from the anterior part and the remaining fibrocartilagnious tissue was 
removed [20]. A 2 mm deep hole was drilled into the ensuing bleeding bone and 
150 μL of PRP was applied to the hole [20]. An additional 150 μL of PRP was 
injected to the repair site intraoperatively [20]. In the control group, saline 
injections of the same amount were applied intraoperatively instead [20].  
The treated rats were next divided into four equal groups of 17: PRP 
group (week 2), control group (week 2), PRP group (week 4), and control group 
(week 4) [20]. After 2 weeks and 4 weeks, rats in both the PRP group and control 
group of each respective week were euthanized (34 total rats at a time) [20]. 
Histological analysis using a semi-quantitative scoring system was performed on 
7 rats per group [20]. Tendon integrity, increases in vascularity and inflammatory 
cells, and the degree of new bone formation were evaluated and compared 
between the groups [20]. Biomechanical analysis of the remaining tendons, 10 
rats per group, was performed as well.  
Results showed that the degree of inflammation and angiogenesis were 
lower in the PRP study groups than the control groups, both at weeks 2 and 4, by 
a statistically significant amount [20]. New bone formation was detected in the 
control group after 4 weeks as well [20]. Biomechanically, tendon thickness and 
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continuity were stronger in PRP-treated specimens 2 weeks postoperatively [20]. 
This may be due to the early effects of platelets on tendon healing. The authors 
reference a study conducted by Kajikawa et al., which reported an increase in 
circulation-derived cells infiltration to the wounded area and proliferation of cells 
with enhanced collagen synthesis at one or two weeks after injury [26]. The cell 
levels subsequently returned to normal [26]. Another reason could be that the 
rotator cuff heals expeditiously in a rodent model, making the difference virtually 
undetectable 4 weeks after injury.  
 Hapa et al. thus concluded that local autologous PRP injections might 
have beneficial effects on initial rotator cuff tendon-to-bone healing and enhance 
initial tendon-to-bone healing remodeling [20]. This represented a relevant 
clinically finding, as no prior prospective randomized controlled clinical studies or 
experimental in vivo studies had been conducted to demonstrate the effect of 
PRP on rotator cuff tendon healing.  
Most studies investigating the efficacy of PRP in rotator cuff repair have 
focused on the use of PRP scaffolds during arthroscopic surgical repair. A 
comprehensive review of five studies investigating PRP in arthroscopic rotator 
cuff repair (Table 2) found no significant difference in the re-tear rates or pain 
improvements between patients who did and did not receive PRP at the time of 
surgery [11]. The authors of this review are quick to admit, however, that the 
clinical heterogeneity among their study selections is a valid concern. The repair 
techniques of three of the studies examined, for instance, was single-row as 
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opposed to the double-row repair techniques used by the other two. Additionally, 
there were noted differences in rotator cuff tear sizes and the number of tendons 
involved among the five studies. Furthermore, three different PRP formulations 
were used among the studies included. Differences among the various PRP 
products included the volume of autologous blood that was drawn, rates at which 
the blood was centrifuged, spin cycles utilized, the use of an activator, and white 
blood cell concentrations, as well as final platelet and GF concentrations [11].  
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Table 2.  Baseline Characteristics of Studies Examined in Systematic Review of the Role of PRP in Arthroscopic 
Rotator Cuff Repair. The repair techniques of 3 of the studies was single-row as opposed to double-row 
Additionally, there were noted differences in rotator cuff tear sizes and the number of tendons involved among the 
five studies. 3 different PRP formulations were used among the studies as well.  
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In a randomized study conducted by Barber et al., 40 patients underwent 
arthroscopic repair of a torn rotator cuff [5]. Two matched groups, 20 patients 
each, were included: patients undergoing rotator cuff repairs without PRP fibrin 
matrix augmentation and patients undergoing repair augmented with two sutured 
PRP constructs [5]. A single-row rotator cuff repair to the normal footprint, without 
tension or marrow vents, was performed by a single surgeon [5]. Postoperative 
rehabilitation was held constant for all patients participating in the study. An 
abduction sling was used to immobilize patients for the first 3 weeks 
postoperatively and converted to a traditional sling for an additional 3 weeks to 
take the arm out of abduction and provide more mobility [5]. At 6 weeks, a home 
exercise program was initiated as well as passive range of motion exercises 
under the guidance of a physical therapist [5]. Postoperative MRI scans were 
obtained at 4 months after progressive strengthening above the shoulder had 
begun and used to evaluate rotator cuff healing [5].  
The authors’ findings showed that twenty patients who received PRP were 
shown to have improved rates of tendon healing and lower rates of re-tearing on 
MRI as compared to controls [5]. Postoperative MRI studies showed a 60% re-
tear rate (12 of 20) in the control group compared to a 30% re-tear rate (6 of 20) 
in the PRP group [5]. Of the 14 tears in the control group initially less than 3 cm 
in anteroposterior length, 7 healed for a 50% rate of healing. Of the 14 tears in 
the PRP construct group that were initially less than 3 cm in length, however, 12 
healed for an 86% heal rate [5]. Interestingly though, the two patient groups did 
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not self-report significantly different improvements in pain and function or display 
significantly disparate clinical outcomes.   
A similar study by Jo et al, demonstrated compelling evidence of 
increased healing rate and decreased re-tear incidence among post-arthroscopic 
repair with PRP patients as visualized on MRI [23]. In this prospective cohort 
study, 42 patients with full-thickness rotator cuff tears were included. Patients 
were informed about the use of PRP before surgery and decided for themselves 
whether to have PRP administered at the time of surgery [23]. 19 patients 
underwent arthroscopic rotator cuff repair with PRP and 23 without [23]. PRP 
was prepared via plateletpheresis and applied in the form of a gel threaded to a 
suture and interposed between tendon and bone. Outcomes were assessed 
preoperatively and then again 3, 6, 12, and 16 months after surgery [23]. Clinical 
outcomes included pain, range of motion, strength, and overall satisfaction. Pain 
was evaluated using the visual analog scale (VAS) and accounted for pain at 
rest, in motion, and at night [23].  
Average pain scores were also measured and compared. Strength 
measured the strength of the supraspinatus, infraspinatus, and subscapularis 
muscles specifically and was determined using a number of functional scoring 
systems: the American Shoulder and Elbow Surgeons (ASES) system, the 
University of California at Los Angeles (UCLA) system, the Disabilities of the 
Arm, Shoulder, and Hand (DASH) system, the Simple Shoulder Test (SST), and 
the Shoulder Pain and Disability Index (SPADI) system [23]. Overall satisfaction 
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was evaluated using a series of yes/no questions concerning the patient’s 
willingness to undergo surgery again, whether they would recommend surgery to 
others, and whether they were able to perform daily tasks and work as they did 
prior to injury [23]. MRI also assessed the structural integrity of the repaired 
tendons at a minimum of 9 months postoperatively. Small and medium size tears 
were grouped as <30 mm and large and massive tears as >30 mm [23].  
The authors determined that PRP gel application to arthroscopic rotator 
cuff repairs did not accelerate recovery with respect to pain, range of motion, 
strength, functional scores, or overall satisfaction as compared to conventional 
repair methods at any time point analyzed. Whereas MRI demonstrated a re-tear 
rare of 26.7% in the PRP group and 41.2% in the conventional group, there was 
no statistically significant difference between the two groups [23]. The results 
therefore suggest that PRP application during arthroscopic repair did not clearly 
demonstrate accelerated recovery clinically or anatomically except for an 
improvement in internal rotation. Nevertheless, as the study may have been 
underpowered to detect clinically important differences in the structural integrity, 
additional investigations are necessary to further determine the effect of PRP. 
These may include the optimization of PRP preparations and a larger 
randomized study powered for healing rate.  
Another arthroscopic study conducted by Randelli et al. showed that 
patients who received PRP reported significantly improved shoulder pain and 
function as compared to control patients [42]. In their prospective, randomized, 
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controlled, double-blind study, 53 patients who underwent arthroscopic rotator 
cuff repair of a complete tear were divided into two groups: a treatment group 
consisting of patients receiving a PRP injection with autologous thrombin during 
repair and a control group [42]. Patients were evaluated using several validated 
outcome scores similarly used by Jo et al. (VAS, SST, and UCLA systems) as 
well as the Constant score and strength in external rotation (SER) system [42]. 
The Constant score was calculated following a detailed physical examination in a 
standardized fashion. The SER was measured in a sitting position with the arms 
neutralized [42]. Pain was assessed using VAS at 3, 7, 14, and 30 days after 
surgery [42]. Structural integrity of repaired tendons was assessed via MRI at a 
minimum of 12 months post-operation, with the exception of 3 patients who 
declined the MRI and were evaluated by ultrasound [42].  
The study showed that pain scores of those in the treatment group were 
significantly lower than those in the control at 3, 7, 14, and 30 days after surgery 
[42]. SST, UCLA, Constant, and SER scores were also significantly higher in the 
treatment group at 3 months after surgery; however, no significant differences 
were noted after 6, 12, and 24 months [42]. In addition, healing rates observed 
on follow-up radiography was not significantly improved in the treatment group 
[42]. The overall findings of the study nonetheless suggest an accelerated repair 
of rotator cuff utilizing PRP application.   
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DISCUSSION 
 
The treatment of RCTs in general has made significant advancements 
over the past few decades, utilizing a mixture of both conservative and non-
conservative measures in an attempt to arrive at optimal healing and relief of 
pain.  Despite conflicting and inconsistent results, a number of published studies 
to date illustrate a general trend towards the effectiveness of PRP treatment, 
suggesting that it may improve patient outcomes and prevent the need for future 
surgery in patients with partial RCTs. Nonetheless, it is still difficult to draw 
definitive conclusions on the efficacy of PRP in rotator cuff repair because of the 
heterogeneous nature in which PRP studies are established.   
As is evident from even the few published studies examined within this 
literature review, clinical studies on PRP conducted thus far all have different 
experimental designs and strength of evidence. These trials have used various 
PRP formulations such as application of activated PRP or incorporation of 
platelet rich fibrin matrix into the repair. Debates continue to exist on the optimal 
concentration of platelets and GF release in PRP formulations that is necessary 
for muscle and tendon healing. Clinically effective PRP has been defined as 
having a minimum of four times the normal concentration of platelets, though 
efficacy has been demonstrated with less concentrated preparations [19]. 
Additionally, the surgical techniques and rehabilitation protocols for patients were 
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not standardized across the trials, making it difficult to assess patient outcome 
measures with regards to PRP in these cases.  
  Though the use of PRP injections is considered safe and acceptable 
among clinicians and patients, the cost of any new therapeutic modality like PRP 
is important to take into consideration, particularly within the current cost-
conscious environment of the US healthcare system. Because of the variances in 
formulation and different preparation systems available for outpatient use, the 
cost of PRP injections is largely dependent on distributing companies and the 
relationship of institutions utilizing PRP injections with these outside sources [19]. 
Additionally, because PRP treatment is still widely regarded as an experimental 
or investigational treatment, many health insurance plans do not reimburse the 
cost of PRP or other autologous blood injection treatments. Taking into account 
the cost of preparation, as well as hospital and radiology fees accompanying the 
procedure, the average cost of a single PRP injection is nearly $2700 (Appendix 
1). It is therefore wise for patients to weigh treatment options before opting to 
undergoing PRP treatment.  
Though not a life-threatening injury, the pain and discomfort associated 
with RCTs and shoulder pain can significantly decrease the value of a patient’s 
lifestyle, hindering one from performing daily activities and accomplishing goals 
as adequately and frequently as one would like. The use of PRP as a minimally 
invasive treatment option with the prospect of a speedier recovery time and less 
morbidity post-treatment, as opposed to surgical interventions, is thus a highly 
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attractive option and one that ought to be further investigated. The use of PRP 
treatment also has significant implications for a number of athletes wishing to 
return to form from injury as quickly as possible. Currently, the World Anti-Doping 
Agency prohibits the administration of endogenous GFs in all elite sports that 
may affect muscle, tendon, or ligament protein synthesis and/or degradation, 
vascularization, energy utilization, and regenerative capacity [53]. Despite the 
presence of GFs, the use of PRP and other platelet-derived preparation were 
removed from the prohibited list in 2011 once studies demonstrated that they do 
not demonstrate any potential for performance enhancement beyond a potential 
therapeutic effect [56].  
Currently, there are few published studies that specifically investigate the 
safety and efficacy of PRP injections to the shoulder as a non-operative 
treatment option for PT RCTs. Even fewer studies seek to compare pre- and 
post-injection imaging to radiographically assess healing of the partially torn 
tendon and, at the same time, to determine a correlation between objective (i.e. 
image reporting) and subjective (i.e. patient report) outcome data. As PRP 
continues to evolve, more substantiated research is needed to understand its 
mechanism of action in addition to clinical data. It is also clear that large, 
multicenter clinical trials are needed to define the best type of PRP to be used 
and for what specific clinical application. The data supporting PRP use thus far 
are immature, but this biologic technology has the potential to transform the 
practice of musculoskeletal medicine and orthopedic surgery.   
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LIST OF JOURNAL ABBREVIATIONS 
 
Acta Biomed Acta Biomedica  
Acta Orthop Traumatol Turc Acta Orthopaedica et Traumatologica Turcica 
Am J Orthop  The American Journal of Orthopedics 
Am J Phys Med Rehabil American Journal of Physical Medicine & 
Rehabilitation 
 
Am J Physiol Regul Integr   American Journal of Physiology-Regulatory,  
Comp Physiol  Integrative & Comparative Physiology 
 
Am J Sports  Med   The American Journal of Sports Medicine 
Arthritis Care Res    Arthritis Care & Research 
Br J Sports Med  British Journal of Sports Medicine 
Clin Orthop Relat Res  Clinical Orthopaedics and Related Research 
Curr Rev Musculoskelet Med Current Reviews in Musculoskeletal Medicine 
Hand Clin  Hand Clinics 
J Am Acad Orthop Surg Journal of the American Academy of 
Orthopaedic Surgeons 
 
JBJS  The Journal of Bone & Joint Surgery 
J Bone Joint Surg Br The Bone & Joint Journal 
J Cell Physiol Journal of Cellular Physiology 
J Shoulder Elbow Surg Journal of Shoulder and Elbow Surgery 
Med Sport Sci Medicine and Sport Science 
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